Andrographolide targets EGFR to impede epithelial�mesenchymal transition in human breast cancer cells
| dc.contributor.author | Chutima Kaewpiboon | |
| dc.contributor.author | Nawong Boonnak | |
| dc.contributor.author | Abdul-Wahab Salae | |
| dc.contributor.author | Sirichatnach Pakdeepromma | |
| dc.contributor.author | Natpaphan Yawut | |
| dc.contributor.author | Young-Hwa Chung | |
| dc.date.accessioned | 2025-07-21T06:11:30Z | |
| dc.date.issued | 2024-06-05 | |
| dc.identifier.doi | 10.1016/j.jpba.2024.116267 | |
| dc.identifier.uri | https://dspace.kmitl.ac.th/handle/123456789/13674 | |
| dc.subject | Andrographolide | |
| dc.subject | SKBR3 | |
| dc.subject | Andrographis Paniculata | |
| dc.subject | Triple-negative breast cancer | |
| dc.subject.classification | Andrographolide Research and Applications | |
| dc.title | Andrographolide targets EGFR to impede epithelial�mesenchymal transition in human breast cancer cells | |
| dc.type | Article |